FindTrial
Sign In

motexafin lutetium

DRUG3 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Adenocarcinoma of the ProstateAdvanced Adult Primary Liver CancerCarcinoma of the AppendixCervical CancerCervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3Fallopian Tube CancerGastrointestinal Stromal Tumor

Phase 1

Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia
TerminatedNCT00005808
National Cancer Institute (NCI)Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3
Start: 2000-12-31Updated: 2013-02-07
Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer
TerminatedNCT00005067
National Cancer Institute (NCI)Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIA Prostate Cancer +2
Start: 2000-02-29Updated: 2013-01-16

Unknown Phase

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
TerminatedNCT00087191
National Cancer Institute (NCI)Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Fallopian Tube Cancer +68
Start: 2004-05-31Updated: 2013-01-16